Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07298642

Extended-field Proton Therapy for Cervical Cancer

Proton Therapy in Extended-field Irradiation for Cervical Cancer

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
Female
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Severe lymphopenia is a common complication of extended-field radiotherapy in cervical cancer, significantly impacting immune function and clinical outcomes. This study aims to evaluate whether proton therapy, with its superior dose distribution, can reduce lymphopenia and improve survival and toxicity profiles compared to photon therapy.

Detailed description

This study is a prospective, observational cohort study designed to evaluate the effects of proton therapy and photon therapy in patients with stage IIIC1 or IIIC2 cervical cancer undergoing extended-field radiotherapy. Primary data collection will include clinical outcomes, radiotherapy-related toxicities, lymphocyte counts, and immune cell subsets (e.g., CD4, CD8, CD19, and CD16+56), measured at baseline, during treatment, and post-treatment. Secondary data collection will involve tissue banking for future translational research projects, including serum, plasma, and whole blood for DNA analysis. The study will be conducted in two tertiary cancer centers (CGMH and NTUCC), with individual patient participation proton or photon treatment approximately 9 weeks, followed by an additional five years for long-term follow-up to assess survival outcomes and late toxicities. This design enables robust comparison of the therapeutic impact of proton and photon therapies on clinical and immunological endpoints, providing evidence to guide personalized treatment decisions in cervical cancer.

Conditions

Interventions

TypeNameDescription
RADIATIONProton extended field radiation therapyProton extended field radiation therapy
RADIATIONPhoton extended field radiation therapyPhoton extended field radiation therapy

Timeline

Start date
2025-09-30
Primary completion
2030-05-01
Completion
2030-05-01
First posted
2025-12-23
Last updated
2025-12-23

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07298642. Inclusion in this directory is not an endorsement.